# An Open Label Trial to Evaluate Efficacy and Safety of Roflumilast 0.3% Cream for Chronic Plaque and Nail Psoriasis

> **NCT07725822** · PHASE4 · RECRUITING · sponsor: **Modern Research Associates, PLLC** · enrollment: 15 (estimated)

## Conditions studied

- Chronic Plaque Psoriasis
- Nail Psoriasis

## Interventions

- **DRUG:** Roflumilast 0.3% topical cream

## Key facts

- **NCT ID:** NCT07725822
- **Lead sponsor:** Modern Research Associates, PLLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-15
- **Primary completion:** 2027-07
- **Final completion:** 2027-08
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07725822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07725822, "An Open Label Trial to Evaluate Efficacy and Safety of Roflumilast 0.3% Cream for Chronic Plaque and Nail Psoriasis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07725822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*